We aim to strengthen our presence in emerging pharma hubs across Tier 2 and Tier 3 cities.

Dr Kiran Badgujar, Founder & Director, Aureole Pharmatech discusses his company's strategic initiatives to strengthen its presence in emerging pharma hubs, innovate through sustainable, customisable lab solutions, future technology investments and more, in an interview with Express Pharma

How do you envision the role of Aureole Pharmatech evolving in response to advancements in the pharma and laboratory equipment industries?

At Aureole Pharmatech, we envision evolving by embracing smart technologies to improve equipment efficiency and precision, while also focusing on sustainability through energy-efficient, eco-friendly solutions. We aim to provide highly customisable, modular equipment that supports personalised medicine and specialised research needs. By staying ahead of regulatory changes, we ensure our equipment meets the highest standards for compliance and quality. Additionally, we are expanding our digital offerings with tools like remote monitoring and data analytics to optimise operational performance. Through strategic partnerships, we aim to drive innovation and address the industry's emerging challenges, keeping our clients at the forefront of pharma and laboratory advancements.

Could you share specific examples of recent innovations, and how these have influenced your product offerings?